• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有两相流模型的不可渗透微血管中的磁靶向——血液的非牛顿特性。

Magnetic targeting in the impermeable microvessel with two-phase fluid model--non-Newtonian characteristics of blood.

机构信息

Department of Mathematics, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal 721 302, India.

出版信息

Microvasc Res. 2010 Sep;80(2):209-20. doi: 10.1016/j.mvr.2010.05.002. Epub 2010 May 18.

DOI:10.1016/j.mvr.2010.05.002
PMID:20478317
Abstract

The present investigation deals with finding the trajectories of the drug dosed magnetic carrier particle in a microvessel with two-phase fluid model which is subjected to the external magnetic field. The radius of the microvessel is divided into the endothelial glycocalyx layer in which the blood is assumed to obey Newtonian character and a core and plug regions where the blood obeys the non-Newtonian Herschel-Bulkley character which is suitable for the microvessel of radius 50 microm. The carrier particles, bound with nanoparticles and drug molecules are injected into the vascular system upstream from malignant tissue, and captured at the tumor site using a local applied magnetic field. The applied magnetic field is produced by a cylindrical magnet positioned outside the body and near the tumor position. The expressions for the fluidic force for the carrier particle traversing in the two-phase fluid in the microvessel and the magnetic force due to the external magnetic field are obtained. Several factors that influence the magnetic targeting of the carrier particles in the microvasculature, such as the size of the carrier particle, the volume fraction of embedded magnetic nanoparticles, and the distance of separation of the magnet from the axis of the microvessel are considered in the present problem. An algorithm is given to solve the system of coupled equations for trajectories of the carrier particle in the invasive case. The trajectories of the carrier particle are found for both invasive and noninvasive targeting systems. A comparison is made between the trajectories in these cases. Also, the present results are compared with the data available for the impermeable microvessel with single-phase fluid flow. Also, a prediction of the capture of therapeutic magnetic nanoparticle in the impermeable microvasculature is made for different radii, distances and volume fractions in both the invasive and noninvasive cases.

摘要

本研究旨在寻找在外磁场作用下,载药磁性载体颗粒在具有两相流模型的微管中的轨迹。微管的半径被分为内皮糖萼层,其中血液被假定为服从牛顿特性,以及核心和塞流区域,其中血液服从适用于半径为 50 微米的微管的非牛顿 Herschel-Bulkley 特性。载体颗粒与纳米颗粒和药物分子结合后被注入到恶性组织上游的血管系统中,并使用局部施加的磁场在肿瘤部位捕获。施加的磁场是由位于体外和靠近肿瘤位置的圆柱形磁铁产生的。获得了载体颗粒在微管两相流中穿越的流体力和外部磁场产生的磁力的表达式。本问题考虑了影响载体颗粒在微血管中磁靶向的几个因素,例如载体颗粒的大小、嵌入磁性纳米颗粒的体积分数以及磁铁与微管轴的分离距离。给出了一种用于求解载体颗粒侵入性轨迹的耦合方程组的算法。找到了载体颗粒在侵入性和非侵入性靶向系统中的轨迹。比较了这些情况下的轨迹。此外,将本研究结果与单相流不可渗透微管的可用数据进行了比较。还对侵入性和非侵入性情况下不同半径、距离和体积分数的不可渗透微血管中治疗性磁性纳米颗粒的捕获进行了预测。

相似文献

1
Magnetic targeting in the impermeable microvessel with two-phase fluid model--non-Newtonian characteristics of blood.具有两相流模型的不可渗透微血管中的磁靶向——血液的非牛顿特性。
Microvasc Res. 2010 Sep;80(2):209-20. doi: 10.1016/j.mvr.2010.05.002. Epub 2010 May 18.
2
Magnetic drug targeting in a permeable microvessel.磁靶向药物在可渗透的微血管中的应用。
Microvasc Res. 2013 Jan;85:77-85. doi: 10.1016/j.mvr.2012.10.011. Epub 2012 Nov 7.
3
Analytical model of magnetic nanoparticle transport and capture in the microvasculature.微血管中磁性纳米颗粒传输与捕获的分析模型。
Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Jun;73(6 Pt 1):061919. doi: 10.1103/PhysRevE.73.061919. Epub 2006 Jun 27.
4
Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.磁靶向给药——局部癌症治疗后磁性载体与化疗药物米托蒽醌的生物分布
J Drug Target. 2003 Apr;11(3):139-49. doi: 10.1080/1061186031000150791.
5
An in vitro study of magnetic particle targeting in small blood vessels.小血管中磁性粒子靶向的体外研究。
Phys Med Biol. 2006 Oct 7;51(19):4869-81. doi: 10.1088/0031-9155/51/19/010. Epub 2006 Sep 14.
6
[A study on the targeting collect character of ferromagnetic drug carrier particles in microvasculature].[铁磁性药物载体颗粒在微血管中的靶向聚集特性研究]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Jun;27(3):533-7.
7
Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting.体外磁靶向给药后动脉模型中磁性纳米颗粒的磁弛豫定量分析
Phys Med Biol. 2009 Sep 21;54(18):N417-24. doi: 10.1088/0031-9155/54/18/N03. Epub 2009 Aug 21.
8
Effects of buoyant and Saffman lift force on magnetic drug targeting in microvessel in the presence of inertia.惯性存在时浮力和萨夫曼升力对微血管中磁靶向药物的影响。
Microvasc Res. 2021 Jan;133:104099. doi: 10.1016/j.mvr.2020.104099. Epub 2020 Nov 2.
9
A model for predicting magnetic particle capture in a microfluidic bioseparator.一种用于预测微流控生物分离器中磁性颗粒捕获的模型。
Biomed Microdevices. 2007 Aug;9(4):451-63. doi: 10.1007/s10544-007-9050-x.
10
Dispersion characteristics of blood during nanoparticle assisted drug delivery process through a permeable microvessel.纳米颗粒辅助药物递送过程中血液在可渗透微血管中的弥散特性。
Microvasc Res. 2014 Mar;92:25-33. doi: 10.1016/j.mvr.2013.12.007. Epub 2014 Jan 7.

引用本文的文献

1
Hemodynamic Effects on Particle Targeting in the Arterial Bifurcation for Different Magnet Positions.不同磁体位置对动脉分叉处粒子靶向的血液动力效应。
Molecules. 2019 Jul 9;24(13):2509. doi: 10.3390/molecules24132509.
2
Capture Efficiency of Biocompatible Magnetic Nanoparticles in Arterial Flow: A Computer Simulation for Magnetic Drug Targeting.动脉血流中生物相容性磁性纳米颗粒的捕获效率:磁性药物靶向的计算机模拟
Nanoscale Res Lett. 2015 Dec;10(1):426. doi: 10.1186/s11671-015-1127-5. Epub 2015 Oct 29.
3
Increased accumulation of magnetic nanoparticles by magnetizable implant materials for the treatment of implant-associated complications.
可磁化植入材料增加磁性纳米颗粒的积累,用于治疗与植入物相关的并发症。
J Nanobiotechnology. 2013 Oct 10;11:34. doi: 10.1186/1477-3155-11-34.